Global Cardiac Marker Market Report 2024

Cardiac Marker Global Market Report 2023 – By Biomarker (Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers), By Product (Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA), By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications), By End User (Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Cardiac Marker Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

The main types of cardiac markers are troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), myoglobin, and other biomarkers. Troponin refers to a protein that is released into the bloodstream when there is damage to the heart muscle and is commonly used to diagnose and monitor heart-related conditions. The different products of cardiac markers are reagents, instruments, chemiluminescence, immunofluorescence, immunochromatography, and ELISA. It is applied for various indications, including myocardial infarction, congestive heart failure, acute coronary syndrome, and other indications, by end users such as laboratory testing facilities, hospital labs, reference labs, contract testing labs, point-of-care testing facilities, and academic institutions.

The global cardiac marker market is segmented -

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

The global cardiac marker market size is expected to grow from $9.40 billion in 2022 to $10.40 billion in 2023 at a compound annual growth rate (CAGR) of 10.66%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cardiac marker market size is expected to reach $16.08 billion in 2027 at a CAGR of 11.50%.

The rising prevalence of cardiac diseases is expected to propel the growth of the cardiac marker market going forward. Cardiac diseases are a group of conditions that affect the structure or operation of the heart and cause a range of medical problems. Cardiac markers are used to diagnose and monitor various cardiac conditions, including heart attacks, angina, heart failure, and other cardiovascular diseases. Thus, the demand for diagnostic tests or cardiac markers has increased. For instance, according to the British Heart Foundation, a cardiovascular research charity in the UK, in England, there were 30,000 more deaths from coronary heart disease from the start of the pandemic to August 2022. A record 346,000 persons were on a cardiac waiting list by the end of August 2022. Therefore, the rising prevalence of cardiac diseases will fuel the cardiac marker market's growth.

Major players in the cardiac marker market are Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Siemens AG, Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, Roche Diagnostics Ltd., ISI Medience Corporation, Ortho Clinical Diagnostics, LSI Medience Corporation, and DiaSorin.

Product innovation is a key trend gaining popularity in the cardiac marker market. Major market players are focusing on innovative solutions to strengthen their position in the market. For instance, in September 2022, MiRxes, a Singapore-based biotechnology company, validated a microRNA-based diagnostic test for the early detection and diagnosis of the illness. When commercialised, the test will enhance MiRxes' portfolio of blood tests for cancer, offering a full range of early detection options to lessen the increasing clinical and socioeconomic burden of life-threatening illnesses, including cancer and cardio-pulmonary disorders.

In July 2020, MBio Diagnostics, a US-based company manufacturing of laboratory instruments and instrumentation systems, merged with Brava Diagnostics for an undisclosed amount. Through this merger, Brava functioned as MBio's human in vitro diagnostics section, where it provided a range of point-of-care assays for which lab-quality data are essential for hastily making choices. Brava Diagnostics is a US-based company that develops and commercializes acute care diagnostic products, including biomarkers, and cardiac markers.

North America was the largest region in the cardiac marker market in 2022. The regions covered in the global cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiac marker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The cardiac marker market consists of sales of C-reactive protein (CRP) and Ischemia-modified albumin (IMA). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cardiac marker market research report is one of a series of new reports from The Business Research Company that provides Cardiac marker market statistics, including global market size, regional shares, competitors with a cardiac marker market share, detailed cardiac marker market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker industry. This cardiac marker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Cardiac Marker Market Characteristics

    3. Cardiac Marker Market Trends And Strategies

    4. Cardiac Marker Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Cardiac Marker Market

    4.2. Ukraine-Russia War Impact On Cardiac Marker Market

    4.3. Impact Of High Inflation On Cardiac Marker Market

    5. Cardiac Marker Market Size And Growth

    5.1. Global Cardiac Marker Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Cardiac Marker Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Cardiac Marker Market Segmentation

    6.1. Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Troponin

    Creatine Kinase-MB (CK-MB)

    B-type Natriuretic Peptide (BNP)

    Myoglobin

    Other Biomarkers

    6.2. Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Reagent

    Instrument

    Chemiluminescence

    Immunofluorescence

    Immunochromatography

    Enzyme-Linked Immunosorbent Assay (ELISA)

    6.3. Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Myocardial Infarction

    Congestive Heart Failure

    Acute Coronary Syndrome

    Other Indications

    6.4. Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Laboratory Testing Facilities

    Hospital Labs

    Reference Labs

    Contract Testing Labs

    Point-Of-Care Testing Facilities

    Academic Institutions

    7. Cardiac Marker Market Regional And Country Analysis

    7.1. Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Cardiac Marker Market

    8.1. Asia-Pacific Cardiac Marker Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Cardiac Marker Market

    9.1. China Cardiac Marker Market Overview

    9.2. China Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Cardiac Marker Market

    10.1. India Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Cardiac Marker Market

    11.1. Japan Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Cardiac Marker Market

    12.1. Australia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Cardiac Marker Market

    13.1. Indonesia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Cardiac Marker Market

    14.1. South Korea Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Cardiac Marker Market

    15.1. Western Europe Cardiac Marker Market Overview

    15.2. Western Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Cardiac Marker Market

    16.1. UK Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Cardiac Marker Market

    17.1. Germany Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Cardiac Marker Market

    18.4. France Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Cardiac Marker Market

    19.1. Eastern Europe Cardiac Marker Market Overview

    19.2. Eastern Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Cardiac Marker Market

    20.1. Russia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Cardiac Marker Market

    21.1. North America Cardiac Marker Market Overview

    21.2. North America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Cardiac Marker Market

    22.1. USA Cardiac Marker Market Overview

    22.2. USA Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Cardiac Marker Market

    23.1. South America Cardiac Marker Market Overview

    23.2. South America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Cardiac Marker Market

    24.1. Brazil Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Cardiac Marker Market

    25.1. Middle East Cardiac Marker Market Overview

    25.2. Middle East Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Cardiac Marker Market

    26.1. Africa Cardiac Marker Market Overview

    26.2. Africa Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Cardiac Marker Market Competitive Landscape And Company Profiles

    27.1. Cardiac Marker Market Competitive Landscape

    27.2. Cardiac Marker Market Company Profiles

    27.2.1. Abbott Laboratories Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Siemens AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Danaher Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. BioMérieux SA

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. F. Hoffmann-La Roche Ltd.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Cardiac Marker Market

    29. Cardiac Marker Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Abbott Laboratories Inc. Financial Performance
  • Table 48: Siemens AG Financial Performance
  • Table 49: Danaher Corporation Financial Performance
  • Table 50: BioMérieux SA Financial Performance
  • Table 51: F. Hoffmann-La Roche Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Abbott Laboratories Inc. Financial Performance
  • Figure 48: Siemens AG Financial Performance
  • Figure 49: Danaher Corporation Financial Performance
  • Figure 50: BioMérieux SA Financial Performance
  • Figure 51: F. Hoffmann-La Roche Ltd. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report